Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 26-Week Trial to Measure the Efficacy and Safety of a Novel Nicotine Replacement Therapy in Smokers in a Naturalistic Environment

NCT01296698 is registered in ClinicalTrials.gov with McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. as lead sponsor.

NCT NCT01296698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01296698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 26-Week Trial to Measure the Efficacy and Safety of a Novel Nicotine Replacement Therapy in Smokers in a Naturalistic Environment
Lead sponsor
McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.
Phase
Phase 3
Overall status
Terminated
Start date
March 31, 2011
Completion date
June 30, 2011
Enrollment
257 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

tobacco dependence